aaron gerds, md: glasdegib and new directions in myelofibrosis treatment
Published 7 years ago • 514 plays • Length 6:43Download video MP4
Download video MP3
Similar videos
-
5:35
aaron gerds: what does the future hold for pacritinib?
-
7:07
phase i/ii trial of glasdegib in patients with primary or secondary myelofibrosis
-
7:07
phase i/ii trial of glasdegib in patients with primary or secondary myelofibrosis
-
2:54
ruxolitinib in the real world: myelofibrosis
-
0:49
dr. gerds on addressing anemia in myelofibrosis
-
1:21
dr. gerds on design and safety analysis of a trial with luspatercept in myelofibrosis
-
1:56
dr. aaron gerds - bio video
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
3:40
pros and cons of ruxolitinib for the treatment of mpns
-
4:22
4. aaron gerds, md, ms-cleveland clinic
-
3:18
1. aaron gerds, md, ms, cleveland clinic
-
2:39
the most study: differences in disease progression amongst patients with low-risk mf
-
0:46
safety of treating myelofibrosis with ruxolitinib – results from jump trial
-
3:56
hematologists get social: medical microblogging on twitter
-
3:04
fda joint session on new aml drugs
-
5:33
ruben mesa, md: momelotinib non-inferior to ruxolitinib in myelofibrosis
-
2:17
tagraxofusp for r/r myelofibrosis shows promise
-
2:02
analyses from comfort trials of ruxolitinib for myelofibrosis
-
10:19
ash 2019 mpn updates-novel therapeutic targets
-
4:15
updates in mpns at ash 2020
-
1:52
ruben mesa, md on myelofibrosis (full interview)